Based on this assumption, the tumor cell suspensions were gated by high GFP expression followed by myeloid markers (CD45 + CD11b+) to minimize the inclusion of the “pseudo-hybrids.” Fig. 1A shows that ~ 1.77% of the GFP + cells expressed the myeloid markers, and the double-positive cells exhibited nuclear GFP and membranous CD11b. This evidence concerns the gene PTPRC and neoplasm.